Cargando…
恶性胸膜间皮瘤免疫检查点抑制剂的研究进展
Malignant pleural mesothelioma (MPM) is a malignant tumor with strong invasiveness, low survival rate and lack of effective treatment options. As the only first-line treatment plan for the advanced MPM, combination of pemetrexed and cisplatin chemotherapy have been existing since the last 20 years....
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246391/ https://www.ncbi.nlm.nih.gov/pubmed/34157803 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.18 |